Altmetric
Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022
File | Description | Size | Format | |
---|---|---|---|---|
Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 .pdf | Published version | 3.21 MB | Adobe PDF | View/Open |
Title: | Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022 |
Authors: | Evans, B Keiser, O Kaiser, L Jombart, T |
Item Type: | Journal Article |
Abstract: | Whilst it is now widely recognised that routine immunisation (RI) was disrupted by the COVID-19 pandemic in 2020, and further so in 2021, the extent of continued interruptions in 2022 and/or rebounds to previous trends remains unclear. We modelled country-specific RI trends using validated estimates of national coverage from the World Health Organisation and United Nation Children's Fund for 182 countries (accounting for > 97% of children globally), to project expected diphtheria, tetanus, and pertussis-containing vaccine first-dose (DTP1), third-dose (DTP3) and measles-containing vaccine first-dose (MCV1) coverage for 2020-2022 based on pre-pandemic trends (from 2000 to 2019). We provide further evidence of peak pandemic immunisation disruption in 2021, followed by tentative recovery in 2022. We report a 3.4% (95 %CI: [2.5%; 4.4%]) decline in global DTP3 coverage in 2021 compared to 2000-2019 trends, from an expected 89.8% to reported 86.4%. This coverage gap reduced to a 2.7% (95 %CI: [1.8%; 3.6%]) decline in 2022, with reported coverage rising to 87.2%. Similar results were seen for DTP1 and MCV1. Whilst partial rebounds are encouraging, global coverage decline translates to a 17-year setback in RI to 2005 levels, and the majority of countries retain coverage at or lower than pre-pandemic levels. The Americas, Africa, and Asia were the most impacted regions; and low- and middle-income countries the most affected income groups. The number of annual Zero Dose (ZD) children - indicating those receiving no immunisations - increased from 12.1 million (M) globally in 2019 to a peak of 16.7 M in 2021, then reduced to 13.1 M in 2022. Overall, we estimate an excess of 8.8 M ZD children cumulatively in 2020-2022 compared to pre-pandemic levels. This work can be used as an objective baseline to inform future interventions to prioritise and target interventions, and facilitate catch-up of growing populations of under- and un-immunised children. |
Issue Date: | 1-Dec-2023 |
Date of Acceptance: | 5-Sep-2023 |
URI: | http://hdl.handle.net/10044/1/107687 |
DOI: | 10.1016/j.jvacx.2023.100383 |
ISSN: | 2590-1362 |
Publisher: | Elsevier |
Journal / Book Title: | Vaccine: X |
Volume: | 15 |
Copyright Statement: | © 2023 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Publication Status: | Published |
Conference Place: | England |
Article Number: | ARTN 100383 |
Online Publication Date: | 2023-09-06 |
Appears in Collections: | Department of Infectious Diseases Faculty of Medicine Imperial College London COVID-19 School of Public Health |
This item is licensed under a Creative Commons License